IL-6 not only serves as a necessary growth factor for MM cells but is also purported to confer bortezomib resistance by inhibiting caspase activity (Colombo et al., 2016; Farrell & Reagan, 2018; Liu et al., 2022). The gene discussed is IL6; the disease is Miyoshi myopathy.